Dasatinib-induced rapid regression and complete molecular remission of multiple subcutaneous tumours presenting as relapsed chronic myeloid leukaemia after cord blood transplantation

MeSH terms

• Antineoplastic Agents / therapeutic use
• Cord Blood Stem Cell Transplantation* / adverse effects
• Dasatinib
• Diagnosis, Differential
• Humans
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
• Male
• Middle Aged
• Neoplasms, Multiple Primary / diagnosis
• Neoplasms, Multiple Primary / drug therapy*
• Neoplasms, Multiple Primary / pathology
• Pyrimidines / therapeutic use*
• Recurrence
• Remission Induction / methods
• Skin Neoplasms / diagnosis*
• Skin Neoplasms / drug therapy*
• Skin Neoplasms / pathology
• Thiazoles / therapeutic use*
• Tumor Burden / drug effects